Photo of Nira Pandya

Nira Pandya

Nira Pandya is a member of the firm’s Technology and IP Transactions Practice Group based in Boston.

Nira advises clients on a broad range of complex commercial transactions and strategic collaborations involving technology, intellectual property, and data.

As part of the firm’s Digital Health Initiative, Nira advises pharmaceutical, medical device, healthcare, and technology companies on the intellectual property and commercial considerations in collaborations and other transactions at the intersection of life sciences and technology. Her experience spans AI-enabled drug discovery and other data and tech-driven collaborations. Nira also co-leads Covington’s quantum computing initiative.

Nira is focused on delivering practical, business-aligned legal guidance -- a key aspect of her approach developed during a secondment with a leading technology company. Earlier in her career, she advised startups and private/public companies on growth, funding, M&A, and other corporate matters, broadening her transactional perspective.

Watch: Nira provides insights on the Life Sciences Industry, as part of our Quantum Computing video series.

 

Contact:Read more about Nira PandyaEmail

The COVID-19 pandemic has created both speed bumps and accelerants for connected and automated vehicle (“CAV”) developments in the United States.  In our Quarterly Update earlier this month, we covered recent legislative and regulatory activity around CAVs, both specifically targeted efforts and those impacting AI and IoT technologies generally.  Although some CAV legislative efforts have been sidelined due to the government’s focus on COVID-19, the pandemic is incentivizing policymakers at the federal and state levels to support CAV-related initiatives.
Continue Reading IoT Update: COVID-19 Drives Forward Connected and Automated Vehicle Legislative and Regulatory Efforts